• Home
  • Latest
  • Fortune 500
  • Finance
  • Tech
  • Leadership
  • Lifestyle
  • Rankings
  • Multimedia

Trendingnow

1

MacKenzie Scott alone accounted for one-third of America's $19.2 billion in megagifts last year

2

Despite his $200 million success, Matthew McConaughey spent a weekend in the desert reading 20 years of bad reviews—he says some of them had ‘a point’

3

Palantir’s billionaire CEO says only two kinds of people will succeed in the AI era: trade workers—‘or you’re neurodivergent’

1

MacKenzie Scott alone accounted for one-third of America's $19.2 billion in megagifts last year

2

Despite his $200 million success, Matthew McConaughey spent a weekend in the desert reading 20 years of bad reviews—he says some of them had ‘a point’

3

Palantir’s billionaire CEO says only two kinds of people will succeed in the AI era: trade workers—‘or you’re neurodivergent’
HealthInsurance

Centene Will Buy Fidelis Care for $3.75 Billion to Enter New York State

Andrew Nusca
By
Andrew Nusca
Andrew Nusca
Editorial Director, Brainstorm
Down Arrow Button Icon
Andrew Nusca
By
Andrew Nusca
Andrew Nusca
Editorial Director, Brainstorm
Down Arrow Button Icon
September 13, 2017, 9:31 AM ET
Google source logo
Add Fortune on Google for similar content.

Publicly-traded health insurer Centene announced late Tuesday that it would buy privately-held Fidelis Care for $3.75 billion.

The deal allows Centene to enter New York State, the second largest managed care state (by membership) in the U.S., and expand its government-sponsored healthcare coverage. Fidelis Care serves more than 1.6 million members and totaled $4.8 billion in revenue for the first six months of 2017. Together, the companies serve almost 14 million people.

SUBSCRIBE: To Fortune’s Brainstorm Health Daily newsletter

The acquisition also gives Centene a leading position in America’s four largest managed care states by membership: California, Florida, New York, and Texas.

“Centene’s and Fidelis Care’s missions are fully aligned in terms of promoting health through high quality, accessible care and services for all and advocating for health policy that accords true dignity and respect for all people, especially the underserved,” Centene’s president and CEO, Michael F. Neidorff, said in a statement.

Centene stock was up almost 7% to $97 in aftermarket trading. The move is expected to improve the company’s earnings per share, it said, and will close in the first quarter of 2018.

About the Author
Andrew Nusca
By Andrew NuscaEditorial Director, Brainstorm
Instagram iconLinkedIn iconTwitter icon

Andrew Nusca is the editorial director of Brainstorm, Fortune's innovation-obsessed community and event series. He also authors Fortune Tech, Fortune’s flagship tech newsletter.

See full bioRight Arrow Button Icon

Latest in Health


Most Popular

Fortune Secondary Logo
Rankings
  • 100 Best Companies
  • Fortune 500
  • Global 500
  • Fortune 500 Europe
  • Most Powerful Women
  • World's Most Admired Companies
  • See All Rankings
  • Lists Calendar
Sections
  • Finance
  • Fortune Crypto
  • Features
  • Leadership
  • Health
  • Commentary
  • Success
  • Retail
  • Mpw
  • Tech
  • Lifestyle
  • CEO Initiative
  • Asia
  • Politics
  • Conferences
  • Europe
  • Newsletters
  • Personal Finance
  • Environment
  • Magazine
  • Education
Customer Support
  • Frequently Asked Questions
  • Customer Service Portal
  • Privacy Policy
  • Terms Of Use
  • Single Issues For Purchase
  • International Print
Commercial Services
  • Advertising
  • Fortune Brand Studio
  • Fortune Analytics
  • Fortune Conferences
  • Business Development
  • Group Subscriptions
About Us
  • About Us
  • Press Center
  • Work At Fortune
  • Terms And Conditions
  • Site Map
  • About Us
  • Press Center
  • Work At Fortune
  • Terms And Conditions
  • Site Map
  • Facebook icon
  • Twitter icon
  • LinkedIn icon
  • Instagram icon
  • TikTok icon
  • YouTube icon

    Recommended For You

    © 2026 Fortune Media IP Limited. All Rights Reserved. Use of this site constitutes acceptance of our Terms of Use and Privacy Policy | CA Notice at Collection and Privacy Notice | Do Not Sell/Share My Personal Information
    FORTUNE is a trademark of Fortune Media IP Limited, registered in the U.S. and other countries. FORTUNE may receive compensation for some links to products and services on this website. Offers may be subject to change without notice.